Top

Published in:

01-06-2010 | Original Article

Impact of caregivers’ unmet needs for supportive care on quality of terminal cancer care delivered and caregiver’s workforce performance

Authors: Sang Min Park, Young Jin Kim, Samyong Kim, Jong Soo Choi, Ho-Yeong Lim, Youn Seon Choi, Young Seon Hong, Si-Young Kim, Dae Seog Heo, Ki Moon Kang, Hyun Sik Jeong, Chang Geol Lee, Do Ho Moon, Jin-Young Choi, In Sik Kong, Young Ho Yun

Published in: Supportive Care in Cancer | Issue 6/2010

Abstract

Goals of work

Family caregivers play an important role in caring for cancer patients, but the impact of caregivers’ unmet needs on the quality of end-of-life (EOL) care they deliver and on their workplace performance are less understood.

Patients and methods

We identified 1,662 family caregivers of cancer patients who had died at any of 17 hospitals in Korea during 2004. The caregivers answered a telephone questionnaire about needs that were not met when they delivered terminal cancer care and how those unmet their needs affected their workplace performance; they also answered the Quality Care Questionnaire-End of Life (QCQ-EOL).

Results

Compared with caregivers who did not have unmet needs, caregivers who had unmet needs for symptom management, financial support, or community support showed poorer QCQ-EOL scores (P < 0.01). Caregivers who had unmet needs for financial support (adjusted odds ratio (aOR) = 7.55; 95% confidential interval (CI) 3.80–15.00), psychosocial support (aOR = 6.24; 95% CI 2.95–13.05), symptom management (aOR = 3.21; 95% CI 2.26–4.54), community support (aOR = 3.82; 95% CI 2.38–6.11), or religious support (aOR = 4.55; 95% CI 1.84–11.26) were more likely to experience work limitations. Caregivers of patients receiving conventional hospital care were more likely to have unmet needs for symptom management (aOR = 1.21; 95% CI 1.00–1.47), psychosocial support (aOR = 1.99; 95% CI 1.37–2.88), and religious support (aOR = 1.73; 95% CI 1.08–2.78) than those of patients receiving palliative hospice care.

Conclusions

Caregivers’ unmet needs negatively affected both the quality of EOL care they delivered and their workplace performance. More investment in caregiver support and public policies that meet caregiver needs are needed, and hospice use should be encouraged.

Kwon YC, Yun YH, Lee KH et al (2006) Symptoms in the lives of terminal cancer patients: which is the most important? Oncology 71:69–76PubMed

Emanuel EJ, Fairclough DL, Slutsman J, Alpert H, Baldwin D, Emanuel LL (1999) Assistance from family members, friends, paid care givers, and volunteers in the care of terminally ill patients. N Engl J Med 341:956–963. doi:10.1056/NEJM199909233411306 CrossRefPubMed

Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL (2000) Understanding economic and other burdens of terminal illness: the experience of patients and their caregivers. Ann Intern Med 132:451–459PubMed

Kissane DW, Bloch S, Burns WI, McKenzies D, Posterino M (1994) Psychological morbidity in the families of patients with cancer. Psychooncology 3:47–56. doi:10.1002/pon.2960030109 CrossRef

Covinsky KE, Goldman L, Cook EF et al (1994) The impact of serious illness on patients' families. JAMA 272:1839–1844. doi:10.1001/jama.272.23.1839 CrossRefPubMed

Rhee YS, Shin DO, Lee KM et al (2005) Korean version of the caregiver quality of life index-cancer (CQOLC-K). Qual Life Res 14:899–904. doi:10.1007/s11136-004-1264-2 CrossRefPubMed

Rabow MW, Hauser JM, Adams J (2004) Supporting family caregivers at the end of life: “they don't know what they don't know”. JAMA 291:483–491. doi:10.1001/jama.291.4.483 CrossRefPubMed

Glajchen M (2004) The emerging role and needs of family caregivers in cancer care. J Support Oncol 2:145–155PubMed

Deeken JF, Taylor KL, Mangan P, Yabroff KR, Ingham JM (2003) Care for the caregivers: a review of self-report instruments developed to measure the burden, needs, and quality of life of informal caregivers. J Pain Symptom Manage 26:922–953. doi:10.1016/S0885-3924(03)00327-0 CrossRefPubMed

10.

Yun YH, Kim SH, Lee KM et al (2006) Patient-reported assessment of quality care at end of life: development and validation of Quality Care Questionnaire-End of Life (QCQ-EOL). Eur J Cancer 42:2310–2317. doi:10.1016/j.ejca.2006.04.010 CrossRefPubMed

11.

Robins JM, Hernan MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11:550–560. doi:10.1097/00001648-200009000-00011 CrossRefPubMed

12.

Kurth T, Walker AM, Glynn RJ et al (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262–270. doi:10.1093/aje/kwj047 CrossRefPubMed

13.

International Agency for Research on Cancer (2002) Cancer incidence in five continents. IARC, Lyons

14.

National Cancer Institute Surveillance, epidemiology, and end results (SEER). http://www.seer.cancer.gov

15.

National Statistical Office Korea (2005) 2004 Annual report on the cause of death statistics (based on vital registration). National Statistical Office, Seoul

16.

Grunfeld E, Coyle D, Whelan T et al (2004) Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ 170:1795–1801. doi:10.1503/cmaj.1031205 PubMed

17.

Stommel M, Given CW, Given BA (1993) The cost of cancer home care to families. Cancer 71:1867–1874. doi:10.1002/1097-0142(19930301)71:5<1867::AID-CNCR2820710525>3.0.CO;2-7 CrossRefPubMed

18.

Hayman JA, Langa KM, Kabeto MU (2001) Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 19:3219–3225PubMed

19.

Philp I, McKee KJ, Meldrum P (1995) Community care for demented and non-demented elderly people: a comparison study of financial burden, service use, and unmet needs in family supporters. BMJ 310:1503–1506PubMed

20.

Covinsky KE, Goldman L, Cook EF (1994) The impact of serious illness on patients' families. JAMA 272:1839–1844. doi:10.1001/jama.272.23.1839 CrossRefPubMed

21.

Davies E, Linklater KM, Jack RH, Clark L, Møller H (2006) How is place of death from cancer changing and what affects it? Analysis of cancer registration and service data. Br J Cancer 95:593–600. doi:10.1038/sj.bjc.6603305 CrossRefPubMed

22.

Lackan NA, Ostir GV, Freeman JL, Mahnken JD, Goodwin JS (2004) Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Med Care 42:116–122. doi:10.1097/01.mlr.0000108765.86294.1b CrossRefPubMed

23.

Kim DG, Kim JS (2008) Strategies for development of hospice reimbursement. J Korean Med Assoc 51:517–523CrossRef

24.

Keam B, Oh DY, Lee SH et al (2008) Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol 38:381–386. doi:10.1093/jjco/hyn031 CrossRefPubMed

25.

Yun YH, Rhee YS, Nam SY et al (2004) Public attitudes toward dying with dignity and hospice, palliative care. Korean Soc Hospice Palliat Care 7:17–28

26.

Korea National Statistical Office (1992–2008) Annual report on the cause of death statistics. National Statistical Office, Seoul

27.

Choi KS, Chae YM, Lee CG et al (2005) Factors influencing preferences for place of terminal care and of death among cancer patients and their families in Korea. Support Care Cancer 13:565–572. doi:10.1007/s00520-005-0809-4 CrossRefPubMed

Title: Impact of caregivers’ unmet needs for supportive care on quality of terminal cancer care delivered and caregiver’s workforce performance
Authors: Sang Min Park
Young Jin Kim
Samyong Kim
Jong Soo Choi
Ho-Yeong Lim
Youn Seon Choi
Young Seon Hong
Si-Young Kim
Dae Seog Heo
Ki Moon Kang
Hyun Sik Jeong
Chang Geol Lee
Do Ho Moon
Jin-Young Choi
In Sik Kong
Young Ho Yun
Publication date: 01-06-2010
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 6/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-009-0668-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Goals of work

Patients and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2010

Is bra discomfort a barrier to exercise for breast cancer patients?

Sleep quality after initial chemotherapy for breast cancer

An oral history of MASCC, its origin and development from MASCC's beginnings to 2009

Letter to the editor

Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function

Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer